Meridian Bioscience’s Campylobacter test cleared
This article was originally published in The Gray Sheet
Executive SummaryFirm will launch its Premier Campy test for detection of Campylobacter infection this week after receiving FDA clearance on Feb. 4, according to a company spokesman. The test launched in Europe in December 2008. Campylobacter infections are the most commonly diagnosed bacteria for food-borne illness in the U.S., and are most often caused by poorly cooked poultry. Around 20 million screens for the bacteria are conducted in the U.S. each year. Meridian says its antigen measuring test is more accurate than the Campylobacter bacteria culturing process, which can be less sensitive due to variable culturing procedures, specimen viability and inhibitory antibiotics in culture media
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”